Abstract
Lipids, one of the major natural products, usually have high biocompatibility and low toxicity. Due to their proper physicochemical properties, they are the most commonly used materials for building modern drug delivery systems, especially nanocarriers. However, to impart new functions or to satisfy special requirements, the lipids can be modified or synthesized. Using lipids or lipid derivatives, various lipid-based drug or gene delivery systems have been developed and show potential in pre-clinical and clinical applications. In this article, the most commonly used lipids are discussed in terms of their properties and functions as drug carrier components, their chemical modifications, the formulation or composition of lipid-based nanocarriers, and their biomedical applications. This article provides a critical view and possible future directions of lipid-based drug delivery strategies.
Keywords: Drug delivery, gene delivery, lipids, lipid conjugate, lipid derivatives, nanocarrier, natural product.
Current Drug Targets
Title:Lipids and Their Derivatives: By-Products Used as Essential Building Blocks for Modern Drug Delivery Systems
Volume: 15 Issue: 5
Author(s): Ying Tu and Lin Zhu
Affiliation:
Keywords: Drug delivery, gene delivery, lipids, lipid conjugate, lipid derivatives, nanocarrier, natural product.
Abstract: Lipids, one of the major natural products, usually have high biocompatibility and low toxicity. Due to their proper physicochemical properties, they are the most commonly used materials for building modern drug delivery systems, especially nanocarriers. However, to impart new functions or to satisfy special requirements, the lipids can be modified or synthesized. Using lipids or lipid derivatives, various lipid-based drug or gene delivery systems have been developed and show potential in pre-clinical and clinical applications. In this article, the most commonly used lipids are discussed in terms of their properties and functions as drug carrier components, their chemical modifications, the formulation or composition of lipid-based nanocarriers, and their biomedical applications. This article provides a critical view and possible future directions of lipid-based drug delivery strategies.
Export Options
About this article
Cite this article as:
Tu Ying and Zhu Lin, Lipids and Their Derivatives: By-Products Used as Essential Building Blocks for Modern Drug Delivery Systems, Current Drug Targets 2014; 15 (5) . https://dx.doi.org/10.2174/1389450115666140306154120
DOI https://dx.doi.org/10.2174/1389450115666140306154120 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Hyaluronidases: A Therapeutic Enzyme
Protein & Peptide Letters Evaluating a Child with Partial Developmental Delay (ParDD), Global Developmental Delay (GDD)/Mental Retardation (MR): Clinical Expertise Based or Evidence-Based?
Current Pediatric Reviews Antiepileptic Drug-Induced Hypersensitivity Syndrome Reactions
Current Drug Safety Registered and Investigational Drugs for the Treatment of Methicillin-Resistant Staphylococcus aureus Infection
Recent Patents on Anti-Infective Drug Discovery The Clinical Spectrum, Diagnosis, Pathogenesis and Treatment of Hashimotos Encephalopathy (Recurrent Acute Disseminated Encephalomyelitis)
Current Medicinal Chemistry Lantibiotic Production by Pathogenic Microorganisms
Current Protein & Peptide Science Serum Tryptophan, Tryptophan Catabolites and Brain-derived Neurotrophic Factor in Subgroups of Youngsters with Autism Spectrum Disorders
CNS & Neurological Disorders - Drug Targets Pharmaceutical Targeting of the Brain
Current Pharmaceutical Design Applications of Lentiviral Vectors for Biology and Gene Therapy of Neurological Disorders
Current Gene Therapy Regulatory Circuitries Coordinated by Transcription Factors and microRNAs at the Cornerstone of Hematopoietic Stem Cell Self-Renewal and Differentiation
Current Stem Cell Research & Therapy Recent Advances in Treatment Approaches of Mucopolysaccharidosis VI
Current Pharmaceutical Biotechnology Animal Models in Neurology: Drawbacks and Opportunities
Current Pharmaceutical Design The Role of Viruses in Neurodegenerative and Neurobehavioral Diseases
CNS & Neurological Disorders - Drug Targets Patents on Potential Drugs to Treat Alzheimer’s Disease: Special Emphasis on Small Peptides
Recent Patents on CNS Drug Discovery (Discontinued) Entry of Oximes into the Brain: A Review
Current Medicinal Chemistry Nanoformulated Antibiotics: the Next Step for Pathogenic Bacteria Control
Current Medicinal Chemistry How to Make a Non-Antigenic Protein (Auto) Antigenic: Molecular Complementarity Alters Antigen Processing and Activates Adaptive-Innate Immunity Synergy
Anti-Cancer Agents in Medicinal Chemistry Rethinking the Excitotoxic Ionic Milieu:The Emerging Role of Zn 2+ in Ischemic Neuronal Injury
Current Molecular Medicine Nanotherapeutics in Neuropathologies: Obstacles, Challenges and Recent Advancements in CNS Targeted Drug Delivery Systems
Current Neuropharmacology Phosphodiesterase Inhibitors as a Target for Cognition Enhancement in Aging and Alzheimer’s Disease: A Translational Overview
Current Pharmaceutical Design